PD-L1 Crosslinking as a New Strategy of 4-1BB Agonism Immunotherapy.
Clin Cancer Res
; 28(15): 3182-3184, 2022 08 02.
Article
in En
| MEDLINE
| ID: mdl-35648093
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
B7-H1 Antigen
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Clin Cancer Res
Year:
2022
Document type:
Article